Chronic Kidney Disease (CKD): Systematic Review of the Cost Effectiveness of SGLT2 Inhibitors and Other Novel Nephroprotective Drugs.

Saved in:
Bibliographic Details
Title: Chronic Kidney Disease (CKD): Systematic Review of the Cost Effectiveness of SGLT2 Inhibitors and Other Novel Nephroprotective Drugs.
Authors: Darbà J; Department of Economics, Universitat de Barcelona, Diagonal 696, 08034, Barcelona, Spain. darba@ub.edu., Ascanio M; BCN Health Economics and Outcomes Research S.L., Barcelona, Spain., Rodríguez A; BCN Health Economics and Outcomes Research S.L., Barcelona, Spain.
Source: PharmacoEconomics [Pharmacoeconomics] 2026 Jun; Vol. 44 (6), pp. 705-725. Date of Electronic Publication: 2026 Mar 22.
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-2027
DOI:10.1007/s40273-026-01611-6